Cowen Inc
STAB

Cowen Inc’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Cowen Inc’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-109,375
Closed – – 286
2016
Q2 		$0 Hold
109,375
– – ﹤0.01% 309
2016
Q1 		$0 Buy
+109,375
New +$368K ﹤0.01% 369

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Cowen Inc's STAB Position: Q3 2016 in Review

Cowen Inc sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2016, closing a stake of 109,375 shares.

Cowen Inc first reported a position in STAB in Q1 2016 and held it in 2 quarters. The position peaked at $0 in Q2 2016. 21 funds tracked by Wall St. Rank hold STAB as of Q3 2016.

  • Cowen Inc reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Cowen Inc sold 109,375 Statera Biopharma, Inc. Common Stock shares in Q3 2016.
  • Cowen Inc first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2016 and held it in 2 quarters.
  • Cowen Inc's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q2 2016.
  • 21 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.